Gene · 51547
Papers2,721
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,721
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| p53 deficiency mediates cisplatin resistance by upregulating RRM2 and crotonylation of RRM2K283 through the downregulation of SIRT7. | Front Mol Biosci | 2024 | 38894712 | PubTator, text mining | PubMed |
| [Effect of SIRT7 on inhibiting the epithelial-mesenchymal transformation in pancreatic cancer cells and related mechanism]. | Zhonghua Zhong Liu Za Zhi | 2024 | 38880736 | PubTator, text mining | PubMed |
| SIRT7 promotes lung cancer progression by destabilizing the tumor suppressor ARF. | Proc Natl Acad Sci U S A | 2024 | 38870055 | PubTator, text mining | PubMed |
| Analysis of the Expression and Prognostic Value of SIRTs in Hepatocellular Carcinoma. | Int J Gen Med | 2024 | 38859909 | PubTator, text mining | PubMed |
| SIRT7 promotes mitochondrial biogenesis to render the adaptive resistance to MAPK inhibition in melanoma. | Biochem Biophys Res Commun | 2024 | 38797153 | PubTator, text mining | PubMed |
| MiR-148a-3p/SIRT7 Axis Relieves Inflammatory-Induced Endothelial Dysfunction. | Int J Mol Sci | 2024 | 38791128 | PubTator, text mining | PubMed |
| Zn2+ improves sepsis-induced acute kidney injury by upregulating SIRT7-mediated Parkin acetylation. | Am J Physiol Renal Physiol | 2024 | 38779758 | PubTator, text mining | PubMed |
| Retraction for: Circular RNA ZNF609 drives tumor progression by regulating the miR-138-5p/SIRT7 axis in melanoma. | Aging (Albany NY) | 2024 | 38748058 | PubTator, text mining | PubMed |
| Dab2 (Disabled-2), an adaptor protein, regulates self-renewal of hair follicle stem cells. | Commun Biol | 2024 | 38702433 | PubTator, text mining | PubMed |
| Sirt7/HIC1 complex participates in hyperglycaemia-mediated EndMT via modulation of SDC1 expression in diabetic kidney disease and metabolic memory. | J Cell Mol Med | 2024 | 38686489 | PubTator, text mining | PubMed |
| Plasma levels of Sirtuin 7 are decreased in patients with essential hypertension. | Clin Biochem | 2024 | 38679273 | PubTator, text mining | PubMed |
| Potential role of SIRT-1 and SIRT-3 as biomarkers for the diagnosis and prognosis of idiopathic pulmonary fibrosis. | Respir Res | 2024 | 38678247 | PubTator, text mining | PubMed |
| Protein succinylation, hepatic metabolism, and liver diseases. | World J Hepatol | 2024 | 38577527 | PubTator, text mining | PubMed |
| Gene expression patterns of Sirtuin family members (SIRT1 TO SIRT7): Insights into pathogenesis and prognostic of Myelodysplastic neoplasm. | Gene | 2024 | 38575099 | PubTator, text mining | PubMed |
| KAT2A-mediated succinylation modification of notch1 promotes the proliferation and differentiation of dental pulp stem cells by activating notch pathway. | BMC Oral Health | 2024 | 38556862 | PubTator, text mining | PubMed |
| Research progress on Sirtuins (SIRTs) family modulators. | Biomed Pharmacother | 2024 | 38522239 | PubTator, text mining | PubMed |
| The sirtuin-associated human senescence program converges on the activation of placenta-specific gene PAPPA. | Dev Cell | 2024 | 38484732 | PubTator, text mining | PubMed |
| SIRT7: A potential prognostic marker and therapeutic target in gallbladder cancer. | Pathol Res Pract | 2024 | 38452583 | PubTator, text mining | PubMed |
| SirT7-mediated transcription of fascin in hyperglycemic glomerular endothelial cells contributes to EndMT in diabetic nephropathy. | Acta Biochim Biophys Sin (Shanghai) | 2024 | 38449390 | PubTator, text mining | PubMed |
| Recent Contributions of Proteomics to Our Understanding of Reversible Nε-Lysine Acylation in Bacteria. | J Proteome Res | 2024 | 38442041 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51547/papers?page=10